# Correction: The impact of tocilizumab treatment on the severity of inflammation and survival rates in sepsis is significantly influence by the timing of administration

**Authors:** Taha Tavaci, Zekai Halici, Elif Cadirci, Mustafa Ozkaraca, Kamber Kasali

PMC · DOI: 10.1007/s10787-025-01748-4 · 2025-04-26

## Full-text entities

- **Diseases:** inflammation (MESH:D007249), sepsis (MESH:D018805)

---
Source: https://tomesphere.com/paper/PMC12213909